Fig 1.
Flowchart of the study protocol.
Flowchart of the study protocol. ESRD: end-stage renal disease; IV-rtPA: intravenous recombinant tissue plasminogen activator; ICH: intracerebral hemorrhage; *secondary ICH: traumatic brain injury, underlying vascular malformation, intracranial tumor, hemorrhagic conversion of an ischemic stroke.
Table 1.
Demographic data of first-ever stroke patients.
Fig 2.
Survival curve of first-ever stroke patients and hazard ratio of post-stroke mortality among different CKD stages.
(A) Adjusted Kaplan-Meier survival curve of first-ever ischemic stroke patients; (B) Adjusted Kaplan-Meier survival curve of first-ever hemorrhagic stroke patients. Adjusted factors include sex, age, hypertension, diabetes mellitus, atrial fibrillation and National Institute of Health Stroke Scale. (C) Hazard ratio for first-ever ischemic stroke mortality; (D) Hazard ratio for first-ever hemorrhagic stroke mortality. CKD: chronic kidney disease.
Table 2.
Hazard ratios for first-ever stroke mortality according to different CKD stages.
Fig 3.
The proportion of different causes of death after the first-ever stroke.
Leading causes of death after first-ever stroke. (A) Within one month after the first-ever ischemic stroke event; (B) within one year after the first-ever ischemic stroke event; (C) within one month after the first-ever hemorrhagic stroke event; (D) within one year after the first-ever hemorrhagic stroke event. CKD: chronic kidney disease.
Table 3.
Top 3 causes of mortality in first-ever stroke patients with different CKD stages.